Article

Nonmedication smoking reduction program for inpatients with chronic schizophrenia: a randomized control design study.

Department of Community Mental Health, University of Haifa, Haifa, Israel.
The Journal of nervous and mental disease (Impact Factor: 1.81). 02/2012; 200(2):142-6. DOI: 10.1097/NMD.0b013e3182438e92
Source: PubMed

ABSTRACT People with schizophrenia are more likely to smoke, and to smoke more frequently, than those without schizophrenia. Furthermore, inpatients smoke even more frequently compared with those living in the community. In light of this, we implemented and assessed a smoking reduction intervention using a wide array of behavioral group techniques and methods in chronic hospitalized schizophrenic clients. Using a controlled design, we randomly assigned chronic schizophrenic clients to either a five-session smoking reduction intervention (n = 35) or a waiting list (WL; n = 18). We assessed self-reported smoking behavior, clinical status (Positive and Negative Syndrome Scale, Hamilton Rating Scale for Depression; Clinical Global Impression Scale for Psychosis), subjective quality of life (Quality of Life Enjoyment and Satisfaction Questionnaire-abbreviated version), and weight before and 3 months after the intervention. The intervention successfully reduced the number of cigarettes smoked compared with nonintervention. No clinical worsening or weight gain was observed. Behavioral group-oriented smoking reduction interventions can significantly reduce smoking behavior in hospitalized chronic clients with schizophrenia.

0 Bookmarks
 · 
103 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Introduction: Persons with a mental disorder smoke at higher rates and suffer disproportionate tobacco-related burden than the general population. The aim of this study was to determine if a smoking cessation intervention initiated during a psychiatric hospitalisation and continued post-discharge was effective in reducing smoking behaviours among persons with a mental disorder. Methods: A randomised controlled trial was conducted at an Australian inpatient psychiatric facility. Participants were 205 patient smokers allocated to a treatment as usual control (n = 101), or a smoking cessation intervention (n = 104) incorporating psychosocial and pharmacological support for four months post-discharge. Follow-up assessments were conducted at one week, two, four and six months post-discharge and included: abstinence from cigarettes, quit attempts, daily cigarette consumption and nicotine dependence. Results: Rates of continuous and seven-day point-prevalence abstinence did not differ between treatment conditions at the six month follow-up, however, point prevalence abstinence was significantly higher for intervention (11.5%) than control (2%) participants at four months (OR = 6.46, p = .01). Participants in the intervention condition reported significantly more quit attempts (F [1,202.5] = 15.23, p = .0001), and lower daily cigarette consumption (F [4, 586] = 6.5, p < .001) and levels of nicotine dependence (F [3, 406] = 8.5, p <.0001) than controls at all follow-up assessments. Conclusions: Post-discharge cessation support was effective in encouraging quit attempts and reducing cigarette consumption up to six months post-discharge. Additional support strategies are required to facilitate longer term cessation benefits for smokers with a mental disorder.
    Nicotine & Tobacco Research 05/2014; · 2.48 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: When patients smoke cigarettes in psychiatric services, it brings to the forefront current ethical and political dilemmas. This study aims to explore the meaning attributed to smoking by mental health patients who smoke and who are hospitalized in a psychiatric ward of a general hospital. This qualitative descriptive study was conducted with 96 smokers who were hospitalized in a psychiatric ward in Brazil. Semi-structured interviews, test of nicotine dependence, and content thematic analysis were carried out. The results show that tobacco has an important role in the lives of psychiatric patients. The meanings they attribute to tobacco use are related to overcoming difficulties that are consequential of mental disorders and of side effects caused by their treatments.
    Issues in Mental Health Nursing 02/2015; 36(2):127-34.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: to identify the degree of nicotine dependence among patients with schizophrenia and other mental disorders hospitalized in a general hospital, correlating these indices with clinical indicators and the meaning for the user.
    Revista Latino-Americana de Enfermagem 07/2014; 22(4):685-692. · 0.54 Impact Factor